Innate Pharma to host conference call and webcast on september 17 for first half 2026 financial results and business update

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, September 17, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT, to provide a business update for the first half of 2026.

 Participants in the call will be: 

• Jonathan Dickinson, Chief Executive Officer
• Markus Jensen, Vice President, Chief Medical Officer
• Yannis Morel, Executive Vice President, Chief Operating Officer
• Frédéric Lombard, Senior Vice President, Chief Financial Officer

Event Details

• Date and time: September 17, 2026, at 2:00 p.m. CEST / 8:00 a.m. EDT

• Webcast link: Click here

• Conference call link: Click here

This information is also available on the Investors section of the Innate Pharma website, www.innate-pharma.com. A replay of the webcast will be available on the Company website for 90 days following the event.